New Potomac Partners, LLC Abb Vie Inc. Transaction History
New Potomac Partners, LLC
- $181 Million
- Q2 2024
A detailed history of New Potomac Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, New Potomac Partners, LLC holds 21,890 shares of ABBV stock, worth $3.79 Million. This represents 2.08% of its overall portfolio holdings.
Number of Shares
21,890
Previous 21,545
1.6%
Holding current value
$3.79 Million
Previous $3.92 Million
4.31%
% of portfolio
2.08%
Previous 2.18%
Shares
27 transactions
Others Institutions Holding ABBV
# of Institutions
3,649Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$29.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$24.8 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.5 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.88 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.33 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $306B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...